Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{51be66a9465b4269b127dc8bd29f17d3,

title = "Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets",

author = "Adamson, {Catherine Sarah} and E.O. Freed",

year = "2009",

month = apr,

doi = "doi: 10.1124/mi.9.2.5",

language = "English",

volume = "9",

pages = "70--74",

journal = "Molecular Interventions",

number = "2",

}

TY - JOUR

T1 - Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets

AU - Adamson, Catherine Sarah

AU - Freed, E.O.

PY - 2009/4

Y1 - 2009/4

UR - http://www.scopus.com/inward/record.url?scp=65949091785&partnerID=8YFLogxK

UR - http://molinterv.aspetjournals.org/content/9/2/70.long

U2 - doi: 10.1124/mi.9.2.5

DO - doi: 10.1124/mi.9.2.5

M3 - Article

VL - 9

SP - 70

EP - 74

JO - Molecular Interventions

JF - Molecular Interventions

IS - 2

ER -